Suchergebnisse

Public choice theory (PCT) has had a powerful influence on political science and, to a lesser extent, public administration. Based on the premise that public officials are rational maximizers of their own utility, PCT has a quite successful record of correctly predicting governmental decisions and policies. This success is puzzling in light of behavioral findings showing that officials do not necessarily seek to maximize their own utility. Drawing on recent advances in behavioral ethics, this article offers a new behavioral foundation for PCT's predictions by delineating the psychological processes that lead well‐intentioned people to violate moral and social norms. It reviews the relevant findings of behavioral ethics, analyzes their theoretical and policy implications for officials' decision making, and sets an agenda for future research.

Do reputational concerns affect the duration of enforcement decisions? We analyze "time to decision" in warning letter processes by two enforcement divisions within the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research. We find that nearly all criticism of these divisions revolves around the FDA's primary consumer protection responsibilities (i.e., underenforcement), thus questioning the validity of the FDA's unique reputation. We also found that as media coverage of the FDA's consumer protection responsibilities becomes more positive, the agency takes enforcement decisions (warning letters) more slowly; in contrast, more critical media coverage leads to quicker action by the FDA. This effect is moderated by media salience; namely, it is found only for periods in which press coverage is relatively intense. An implication of this conditional relationship is an ability to assess the baseline role of reputation in the organization, namely, how concerned it is regarding its reputation in the absence of exogenous challenges. Adapted from the source document.

How does individual political efficacy affect the construction of policy preferences? This article presents a model of individual-level politicization of policy preference, which draws on psychological and political explanations and posits that greater external political efficacy results in a stronger effect of political ideology on concrete policy preference. Two empirical studies that test this hypothesis are reported: an original survey experiment conducted in Israel, and an analysis that relies on the 2002 wave of the European Social Survey. The empirical findings support the hypothesis. In contrast to the established conviction that no association exists between political efficacy and policy preferences, these findings reveal that external political efficacy has a polarizing effect on expressed policy preferences. Adapted from the source document.

How does individual political efficacy affect the construction of policy preferences? This article presents a model of individual-level politicization of policy preference, which draws on psychological and political explanations and posits that greater external political efficacy results in a stronger effect of political ideology on concrete policy preference. Two empirical studies that test this hypothesis are reported: an original survey experiment conducted in Israel, and an analysis that relies on the 2002 wave of the European Social Survey. The empirical findings support the hypothesis. In contrast to the established conviction that no association exists between political efficacy and policy preferences, these findings reveal that external political efficacy has a polarizing effect on expressed policy preferences.

Do reputational concerns affect the duration of enforcement decisions? We analyze "time to decision" in warning letter processes by two enforcement divisions within the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research. We find that nearly all criticism of these divisions revolves around the FDA's primary consumer protection responsibilities (i.e., underenforcement), thus questioning the validity of the FDA's unique reputation. We also found that as media coverage of the FDA's consumer protection responsibilities becomes more positive, the agency takes enforcement decisions (warning letters) more slowly; in contrast, more critical media coverage leads to quicker action by the FDA. This effect is moderated by media salience; namely, it is found only for periods in which press coverage is relatively intense. An implication of this conditional relationship is an ability to assess the baseline role of reputation in the organization, namely, how concerned it is regarding its reputation in the absence of exogenous challenges.